| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |